Skip to main
OPCH

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 60%
Hold 10%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health is poised for strong financial performance in the upcoming years, driven by a de-risked product portfolio and partnerships with healthcare providers and payors. The company has exceeded analyst expectations for adjusted EPS and adjusted EBITDA in the first quarter, and its management has maintained their guidance for these metrics for FY/26. Additionally, Option Care's expected 4% revenue growth in FY/26 is expected to be driven by its collaboration with healthcare professionals and commitment to providing cost-effective care. These factors, along with the potential for a strong stock performance, have led to a positive outlook on the company's stock.

Bears say

Option Care Health is facing several headwinds that are expected to impact its revenue and gross profit, with a particularly negative impact from changes in the insurance landscape for autoimmune and chronic inflammatory disorders. Additionally, slower growth for certain specialty therapies and launch delays for rare and orphan products are expected to further hinder growth. While management remains confident in its ability to improve margins, there are risks to growth and competition in the infusion market that could weigh on profitability. Additionally, the company's exposure to Stelara is expected to significantly decrease in the future, providing some stabilization. Overall, while there are some positive aspects to the company's performance, the negative factors outweigh them, leading to a negative outlook on the stock.

OPCH has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 60% recommend Buy, 10% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 10 analysts, OPCH has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $35.20, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $35.20, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.